| 000 | 01625 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514054533.0 | ||
| 264 | 0 | _c20030213 | |
| 008 | 200302s 0 0 eng d | ||
| 022 | _a0385-5600 | ||
| 024 | 7 |
_a10.1111/j.1348-0421.2002.tb02761.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFunatogawa, Kenji | |
| 245 | 0 | 0 |
_aUse of immunoglobulin enriched bovine colostrum against oral challenge with enterohaemorrhagic Escherichia coli O157:H7 in mice. _h[electronic resource] |
| 260 |
_bMicrobiology and immunology _c2002 |
||
| 300 |
_a761-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAging _ximmunology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 | _aCattle |
| 650 | 0 | 4 |
_aCecum _xmicrobiology |
| 650 | 0 | 4 | _aColony Count, Microbial |
| 650 | 0 | 4 |
_aColostrum _ximmunology |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDrug Resistance, Bacterial |
| 650 | 0 | 4 |
_aEscherichia coli Infections _xprevention & control |
| 650 | 0 | 4 |
_aEscherichia coli O157 _xdrug effects |
| 650 | 0 | 4 |
_aEscherichia coli Vaccines _ximmunology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aImmunoglobulins _ximmunology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 |
_aStreptomycin _xtherapeutic use |
| 700 | 1 | _aIde, Takayuki | |
| 700 | 1 | _aKirikae, Fumiko | |
| 700 | 1 | _aSaruta, Katsutoshi | |
| 700 | 1 | _aNakano, Masayasu | |
| 700 | 1 | _aKirikae, Teruo | |
| 773 | 0 |
_tMicrobiology and immunology _gvol. 46 _gno. 11 _gp. 761-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1348-0421.2002.tb02761.x _zAvailable from publisher's website |
| 999 |
_c12319645 _d12319645 |
||